Antibodies Against the Plasmodium vivax Apical Membrane Antigen 1 From the Belem Strain Share Common Epitopes Among Other Worldwide Variants.

Autor: França ACB; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil., Françoso KS; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil., Marques RF; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil., Trossini GHG; Department of Pharmacy, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil., Gomes RA; Department of Pharmacy, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil., Póvoa MM; Instituto Evandro Chagas, Ananindeua, Brazil., Cunha MG; Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Brazil., Silveira ELV; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil., Soares IS; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.

Publikováno v: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2021 Mar 16; Vol. 11, pp. 616230. Date of Electronic Publication: 2021 Mar 16 (Print Publication: 2021).

Febrile temperatures increase in vitro antibody affinity for malarial and dengue antigens.

Autor: Stan RC; Department of Immunology, Institute for Biomedical Sciences, University of São Paulo, Brazil., Françoso KS; Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo, Brazil., Alves RPS; Department of Microbiology, Institute for Biomedical Sciences, University of São Paulo, Brazil., Ferreira LCS; Department of Microbiology, Institute for Biomedical Sciences, University of São Paulo, Brazil., Soares IS; Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo, Brazil., de Camargo MM; Department of Immunology, Institute for Biomedical Sciences, University of São Paulo, Brazil.

Publikováno v: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2019 Apr 03; Vol. 13 (4), pp. e0007239. Date of Electronic Publication: 2019 Apr 03 (Print Publication: 2019).

Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge.

Autor: de Camargo TM; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil., de Freitas EO; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil.; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, The Henry Wellcome Building for Molecular Physiology, Roosevelt Drive, Oxford, UK., Gimenez AM; Center of Cellular and Molecular Therapy, Department of Microbiology, Immunology and Parasitology, Federal University of São Paulo, São Paulo, SP, Brazil., Lima LC; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil., de Almeida Caramico K; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil., Françoso KS; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil., Bruna-Romero O; Department of Microbiology and Immunology, Federal University of Santa Catarina, Florianópolis, SC, Brazil., Andolina C; Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine Research building, University of Oxford Old Road campus, Oxford, UK., Nosten F; Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine Research building, University of Oxford Old Road campus, Oxford, UK., Rénia L; Singapore Immunology Network, Biopolis, Agency for Science Technology and Research, Singapore, Singapore., Ertl HCJ; The Wistar Institute, Philadelphia, PA, USA., Nussenzweig RS; Michael Heidelberger Division, Department of Pathology, New York University School of Medicine, New York, NY, USA., Nussenzweig V; Michael Heidelberger Division, Department of Pathology, New York University School of Medicine, New York, NY, USA., Rodrigues MM; Center of Cellular and Molecular Therapy, Department of Microbiology, Immunology and Parasitology, Federal University of São Paulo, São Paulo, SP, Brazil., Reyes-Sandoval A; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, The Henry Wellcome Building for Molecular Physiology, Roosevelt Drive, Oxford, UK., Soares IS; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil. isoares@usp.br.

Publikováno v: Scientific reports [Sci Rep] 2018 Jan 18; Vol. 8 (1), pp. 1118. Date of Electronic Publication: 2018 Jan 18.

Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite.

Autor: Gimenez AM; Department of Microbiology, Immunology and Parasitology, Center of Cellular and Molecular Therapy (CTCMol), Federal University of São Paulo, São Paulo, Brazil., Lima LC; Department of Microbiology, Immunology and Parasitology, Center of Cellular and Molecular Therapy (CTCMol), Federal University of São Paulo, São Paulo, Brazil.; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil., Françoso KS; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil., Denapoli PMA; Department of Microbiology, Immunology and Parasitology, Center of Cellular and Molecular Therapy (CTCMol), Federal University of São Paulo, São Paulo, Brazil., Panatieri R; Unit of Malaria Infection and Immunity, Institut Pasteur, Paris, France.; Department of Parasitology, University of São Paulo, São Paulo, Brazil., Bargieri DY; Department of Parasitology, University of São Paulo, São Paulo, Brazil., Thiberge JM; Unit of Malaria Infection and Immunity, Institut Pasteur, Paris, France., Andolina C; Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine Research Building, University of Oxford, Oxford, United Kingdom., Nosten F; Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine Research Building, University of Oxford, Oxford, United Kingdom., Renia L; Singapore Immunology Network, Biopolis, Agency for Science Technology and Research, Singapore, Singapore., Nussenzweig RS; New York University School of Medicine, New York, NY, United States., Nussenzweig V; New York University School of Medicine, New York, NY, United States., Amino R; Unit of Malaria Infection and Immunity, Institut Pasteur, Paris, France., Rodrigues MM; Department of Microbiology, Immunology and Parasitology, Center of Cellular and Molecular Therapy (CTCMol), Federal University of São Paulo, São Paulo, Brazil., Soares IS; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil.

Publikováno v: Frontiers in immunology [Front Immunol] 2017 Oct 11; Vol. 8, pp. 1275. Date of Electronic Publication: 2017 Oct 11 (Print Publication: 2017).

A recombinant multi-antigen vaccine formulation containing Babesia bovis merozoite surface antigens MSA-2a 1 , MSA-2b and MSA-2c elicits invasion-inhibitory antibodies and IFN-γ producing cells.

Autor: Gimenez AM; CTCMOL, Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo-Escola Paulista de Medicina, Rua Mirassol, 207, São Paulo, 04044-010, SP, Brazil., Françoso KS; Departamento de Análises Clínicas e Toxicológicas, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, 05508-900, São Paulo, SP, Brazil., Ersching J; CTCMOL, Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo-Escola Paulista de Medicina, Rua Mirassol, 207, São Paulo, 04044-010, SP, Brazil., Icimoto MY; Departamento de Biofísica, Universidade Federal de São Paulo, CEP 04023-062, São Paulo, Brazil., Oliveira V; Departamento de Biofísica, Universidade Federal de São Paulo, CEP 04023-062, São Paulo, Brazil., Rodriguez AE; Instituto de Patobiologia, CICVyA, INTA-Castelar, 1686, Hurlingham, Argentina., Schnittger L; Instituto de Patobiologia, CICVyA, INTA-Castelar, 1686, Hurlingham, Argentina.; CONICET, C1033AAJ, Ciudad Autonoma de Buenos Aires, Argentina., Florin-Christensen M; Instituto de Patobiologia, CICVyA, INTA-Castelar, 1686, Hurlingham, Argentina.; CONICET, C1033AAJ, Ciudad Autonoma de Buenos Aires, Argentina., Rodrigues MM; CTCMOL, Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo-Escola Paulista de Medicina, Rua Mirassol, 207, São Paulo, 04044-010, SP, Brazil., Soares IS; Departamento de Análises Clínicas e Toxicológicas, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, 05508-900, São Paulo, SP, Brazil. isoares@usp.br.

Publikováno v: Parasites & vectors [Parasit Vectors] 2016 Nov 14; Vol. 9 (1), pp. 577. Date of Electronic Publication: 2016 Nov 14.